Related Experiment Video
Updated: Aug 12, 2026

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation
Published on: November 7, 2020
Liver transplantation: current concepts
1Department of Surgery, University Hospital, London, Ont.
Insights
Liver transplantation is a successful treatment for end-stage liver disease, with about 70% of patients surviving one year. Improved techniques and immunosuppression contribute to good long-term outcomes and quality of life.
Area of Science:
- Hepatology
- Transplant Surgery
- Immunology
Background:
- Liver transplantation is the primary treatment for irreversible end-stage liver disease in both children and adults.
- Common indications include biliary atresia in children and nonalcoholic cirrhosis in adults.
- Its role in treating liver cancer is currently limited.
Purpose of the Study:
- To review the current status and success factors of liver transplantation.
- To highlight the indications, outcomes, and quality of life for liver transplant recipients.
Main Methods:
- Review of current literature and clinical practices in liver transplantation.
- Analysis of recipient selection criteria, surgical techniques, and post-operative care.
- Evaluation of immunosuppression strategies, particularly cyclosporine.
Main Results:
- Approximately 70% of liver transplant recipients achieve one-year survival.
- Patients generally experience good quality of life and rehabilitation post-transplantation.
- Blood group compatibility is preferred, but tissue typing is not a significant factor in recipient selection.
Conclusions:
- Liver transplantation is a highly successful procedure for end-stage liver disease.
- Success is attributed to careful patient selection, advanced surgical and anesthetic methods, enhanced perioperative care, accurate rejection diagnosis, and effective immunosuppression.
- The procedure offers excellent long-term survival prospects and improved quality of life for recipients.
Abstract:
In this decade liver transplantation has been established as the preferred treatment for children and adults with irreversible end-stage liver disease. Biliary atresia in children and nonalcoholic cirrhosis in adults are the most common indications for the procedure. Transplantation currently plays only a minor role in the treatment of hepatic malignant disease. Blood group compatibility between donor and recipient is preferred, but histocompatibility matching (tissue typing) currently has no significant role in the selection of recipients. Approximately 70% of recipients survive for 1 year, and these patients have an excellent prospect of long-term survival. The emerging evidence indicates that the quality of life and rehabilitation of most liver recipients are good. The current success of liver transplantation can be attributed to critical selection of recipients, modern anesthetic and surgical techniques, improved perioperative care, accurate diagnosis of rejection and superior immunosuppression with cyclosporine.
Related Concept Videos
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure

